Plain-English translation of NCT03011541 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called bone marrow derived stem cells (BMSC) to help people who have lost vision from diseases affecting the retina or optic nerve. The stem cells are collected from your own bone marrow using standard surgical techniques, then injected into or around your eye. Researchers will follow you for 12 months with regular eye exams to see if this treatment helps improve or stabilize your vision.
Many retinal and optic nerve diseases cause permanent vision loss that doesn't improve with current treatments. This trial is exploring whether stem cells can help repair damage and restore some vision in people with these hard-to-treat conditions.
You likely qualify if…
You likely don't qualify if…
If you enroll, your own bone marrow will be collected using standard surgical techniques, and stem cells will be isolated from it. These cells will then be injected into or around your eye — the injections may be placed behind the eye, around the eye muscle, or given through your bloodstream. You will return for comprehensive eye exams with imaging and vision tests every month for 12 months to monitor your progress and safety.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States
Austria
United Arab Emirates